Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell sialic acid receptors are terminal carbohydrate residues, specifically N-acetylneuraminic acid (Neu5Ac), located on the glycans of glycoproteins and glycolipids on the surface of host cells (Varki, 2008). These receptors serve as the critical attachment point for the Influenza B virus hemagglutinin (HA) protein, which facilitates viral entry into the respiratory epithelium (Ni et al., 2013). Influenza B virus HA exhibits a binding preference for alpha-2,6-linked sialic acids, which are the predominant linkage type in the human upper respiratory tract, although it can also bind to alpha-2,3-linked sialic acids found in the lower respiratory tract (Velkov et al., 2013). The interaction between HA and these receptors triggers receptor-mediated endocytosis, a vital step in the viral life cycle. Therapeutic interventions targeting this interaction include the development of sialidases like DAS181 (Fludase), which cleave the sialic acid residues from the host cell surface to prevent viral docking (Belser et al., 2007). Because sialic acids are involved in numerous physiological processes, including cell signaling and immune regulation, therapeutic targeting must balance antiviral efficacy with potential impacts on normal cellular functions.
Enzymatic cleavage of terminal sialic acid residues from the host cell surface to prevent viral attachment and entry.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell sialic acid receptor (SA receptor).